Accounting reportsPreviously
|
Name | NOVARTIS FARMA, OOO |
|---|
INN | 7705772224 |
|---|
KPP | 771401001 |
|---|
OGRN | 1067761778083 |
|---|
OKPO | 98959705 |
|---|
Address | 125315, G.MOSKVA, pr-kt. Leningradskiy, d. 70 |
|---|
Phone | +7 (495) 967-12-70 Contact details |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 46.46.1 | Core activity | Wholesale of furniture, carpets and lighting equipment | | 47.73 | Additional activity | Retailing drugs in specialized stores (pharmacies) | | 47.74 | Additional activity | Retailing products used for medical purposes, orthopedic goods in specialized stores | | All types of activities | | 47.75 | Additional activity | Retailing of cosmetics and personal hygiene products in specialized stores | | 70.22 | Additional activity | Advice on business and management | | 71.20.9 | Additional activity | Activities for technical control, testing and other analysis | | 73.1 | Additional activity | Advertising | | 73.20.1 | Additional activity | Market and opinion research | | 82.99 | Additional activity | Other business support services to businesses and individuals not otherwise specified |
Registration date | 27.12.2006 |
|---|
Registering department | Mezhrayonnaya inspektsiya Federal'noy nalogovoy sluzhby N 46 po g. Moskve |
|---|
|
NOVARTIS FARMA, OOO (Moscow; INN 7705772224) was registered on 27 Dec 2006. The company's authorized capital as of July 1, 2012 was 20000000 rub. Type of ownership of NOVARTIS FARMA, OOO - Limited liability companies. Form of ownership of NOVARTIS FARMA, OOO - Property of foreign legal entities. Principal activities of NOVARTIS FARMA, OOO: wholesale of furniture, carpets and lighting equipment (46.46.1), retailing drugs in specialized stores (pharmacies) (47.73), retailing products used for medical purposes, orthopedic goods in specialized stores (47.74). |
Economic indicators2024
Net profit (RAS) of NOVARTIS FARMA, OOO dropped in 2024 by 22.47% to 588.57 million RUB from 759.13 million RUB over the same period in 2023, the company informed. Revenue decreased in the accounting period by 1.94% to 54.27 billion RUB from 55.34 billion RUB in 2023; cost of goods sold decreased by 3.09% to 41.71 billion RUB from 43.04 billion RUB; sales profit fell by 1.54% to 3.02 billion RUB from 3.07 billion RUB. 2023
Net profit (RAS) of NOVARTIS FARMA, OOO made up 759.13 million RUB over 2023 compared to net loss of 740.96 million RUB over 2022, the company informed. Revenue increased in the accounting period by 17.28% to 55.34 billion RUB from 47.19 billion RUB over 2022; cost of goods sold grew by 17.47% to 43.04 billion RUB from 36.64 billion RUB; sales profit went up 1.91 times to 3.07 billion RUB from 1.61 billion RUB. 2022
Net loss (RAS) of NOVARTIS FARMA, OOO increased 2.64 times to 740.96 million RUB from 281.08 million RUB over 2021, the company informed. Revenue increased in the accounting period by 18.79% to 47.19 billion RUB from 39.72 billion RUB over 2021; cost of goods sold grew by 19.80% to 36.64 billion RUB from 30.58 billion RUB; sales profit went up by 38.24% to 1.61 billion RUB from 1.17 billion RUB. 2021
Net loss (RAS) of NOVARTIS FARMA, OOO dropped over 2021 by 28.67% to 281.08 million RUB from 394.07 million RUB KAgent.Entities.Balance, the company informed. Revenue increased in the accounting period by 24.70% to 39.72 billion RUB from 31.86 billion RUB over 2020; cost of goods sold grew by 26.07% to 30.58 billion RUB from 24.26 billion RUB; sales profit went up 1.56 times to 1.17 billion RUB from 744.86 million RUB. 2020
Net loss (RAS) of NOVARTIS FARMA, OOO dropped over 2020 by 10.48% to 394.07 million RUB from 440.22 million RUB KAgent.Entities.Balance, the company informed. Revenue increased in the accounting period by 13.21% to 31.86 billion RUB from 28.14 billion RUB over 2019; cost of goods sold grew by 18.29% to 24.23 billion RUB from 20.48 billion RUB; sales profit went up by 15.90% to 776.41 million RUB from 669.89 million RUB. 2018
Net profit (RAS) of NOVARTIS FARMA, OOO made up 514.13 million RUB over 2018 compared to net loss of 351.35 million RUB over 2017, the company informed. Revenue increased in the accounting period by 20.40% to 21.90 billion RUB from 18.18 billion RUB over 2017; cost of goods sold grew by 15.82% to 15.24 billion RUB from 13.16 billion RUB; sales profit went up 3.11 times to 1.50 billion RUB from 481.77 million RUB. 2017
Net loss (RAS) of NOVARTIS FARMA, OOO dropped over 2017 by 35.56% to 351.35 million RUB from 545.26 million RUB KAgent.Entities.Balance, the company informed. Revenue increased in the accounting period by 31.86% to 18.18 billion RUB from 13.79 billion RUB over 2016; cost of goods sold grew by 31.63% to 13.16 billion RUB from 10.00 billion RUB; sales profit went up by 4.38% to 481.77 million RUB from 461.57 million RUB. 2016
Net loss (RA) of NOVARTIS FARMA, OOO made up 545.26 million RUB over 2016 compared to net profit of 34.88 million RUB over 2015, the company informed. Revenue decreased in the accounting period by 8.66% to 13.79 billion RUB from 15.10 billion RUB in 2015; cost of goods sold decreased by 14.38% to 10.00 billion RUB from 11.68 billion RUB; sales profit fell by 25.83% to 461.57 million RUB from 622.28 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|